Shenzhen Edge Medical Co., Ltd. (EDGE MEDICAL-B) filed its Monthly Return for Equity Issuers for the period ended 31 March 2026, confirming that no changes occurred in either registered or issued share capital during the month.

Total registered share capital remained at RMB 391.88 million, split between 327.76 million H-shares listed on the Hong Kong Stock Exchange and 64.12 million unlisted domestic shares. Par value for all shares is RMB 1, and the company reported zero treasury shares.

Issued H-shares stood unchanged at 327.76 million, while unlisted shares held steady at 64.12 million. The company reported no new share options, warrants, convertible securities, or other equity-linked instruments, and no share repurchases or cancellations were undertaken.

Edge Medical affirmed that it met the Hong Kong Main Board’s minimum public-float requirement of 15 % as of 31 March 2026. The confirmation was signed by Joint Company Secretary Wu Mengyuan and submitted to Hong Kong Exchanges and Clearing Limited on 8 April 2026.